• Home
  • NEW DAY MEDICINE
  • 8 (70) 2024
  • 12 -8 (70) 2024 - Bekmatova Sh.K., Yusupova Sh.B. - CHARACTERISTICS OF THE MAIN TRIPLE PROPHYLAXIS OF ISCHEMIC HEART DISEASE AFTER THE METABOLIC SYNDROME

12 -8 (70) 2024 - Bekmatova Sh.K., Yusupova Sh.B. - CHARACTERISTICS OF THE MAIN TRIPLE PROPHYLAXIS OF ISCHEMIC HEART DISEASE AFTER THE METABOLIC SYNDROME

CHARACTERISTICS OF THE MAIN TRIPLE PROPHYLAXIS OF ISCHEMIC HEART DISEASE AFTER THE METABOLIC SYNDROME

Bekmatova Sh.K. - Tashkent Medical Academy

Yusupova Sh.B. - Tashkent Medical Academy

Ikromov M.J. - Tashkent Medical Academy

Resume

Metabolic syndrome (MS). This syndrome includes a number of diseases and risk factors, including impaired glucose tolerance (IGT), overweight (OTV) and obesity, arterial hypertension (AH), dyslipoproteinemia.

Keywords: Metabolic syndrome (MS). Glucose tolerance (IGT), overweight (OTV) and obesity, arterial hypertension (AH), dyslipoproteinemia.

First page

60

Last page

62

For citation:Bekmatova Sh.K., Yusupova Sh.B., Ikromov M.J. - CHARACTERISTICS OF THE MAIN TRIPLE PROPHYLAXIS OF ISCHEMIC HEART DISEASE AFTER THE METABOLIC SYNDROME//New Day in Medicine 8(70)2024 60-62 https://newdayworldmedicine.com/en/new_day_medicine/8-70-2024

List of References

  1. Бекматова Ш.К., Машарипова Ю.К., Юсупова Ш.Б., Макарова Е.В Возрастная зависимость компонентов метаболического синдрома //Евразийский вестник педиатрии Ташкент, 2022;2(13):67-70.
  2. Bekmatova Sh.K.,Yusupova Sh.B. Modern ideas about the metabolic syndrome, its main components and risk factors //Международный научный журнал «Научныйимпульс» часть 2 Москва, 2022 сентябрь;2(100):825-826.
  3. Каюмов У.К. Рецепт от всех болезней. / Здоровье Узбекистана 2019;3(36):4-7.
  4. Каюмов У.К. Нормативы уровня гликемии среди мужчин 20-69 лет г. Ташкента // Методические рекомендации, г. Ташкент, 2002. С.8.
  5. Averin E.E. Kardiyovaskulyar remodeling, surunkali yurak etishmovchiligi va depressiya bilan og'rigan bemorlarda proinflamatuar sitokinlar va kollagenga immun javoblar darajasining oshishi / E.E. Averin, S.I. Chernova, I.A. Zborovskaya // Yangi tibbiy exnologiyalar Byulleteni. 2010;2:96-98.
  6. Arutyunov G.P. surunkali yurak etishmovchiligi bilan og'rigan bemorlarda gipotrofiyaning tarqalishi, klinik ahamiyati va ovqatlanishni qo'llab-quvvatlash samaradorligi / G.P. Arutyunov, O.I. Kostyukevich, N.A. Bylova //Eksperimental va klinik gastroenterologiya. 2009;2:22-33.
  7. Yurak va qon tomirlari kasalliklari (kardiologiya bo'yicha qo'llanma, vol. 4) / ed. E. I. Chazov tomonidan. - /M.: Tibbiyot, 1982. - 608 p.
  8. Шамуратова Н.Ш., Зокирходжаев Ш.Я., Дусчанов Б.А. Парҳез овқатланишнинг қандли диабетда самарадорлиги. – 2023.
  9. Glutkina N. V. metabolik sindrom va yurak-qon tomir kasalliklari: patofiziologik jihatlar / N. V. Glutkina, V. M. Pirochkina //Grodno Davlat tibbiyot universiteti jurnali. 2012;2(38):15-19.
  10. Evzerixina A. V. CHF bilan og'rigan bemorlarni uzluksiz o'qitishning turli shakllarining klinik samaradorligi: tibbiyot fanlari nomzodi dissertatsiyasining referati / A. V. Evzerixina, RSMU. - M., 2009 - - 25 P.
  11. Zokirova A.N. Yurak ishemik kasalligi, surunkali yurak etishmovchiligi va atriyal fibrilatsiyaga chalingan bemorlarda yopishqoq endotelial funktsiyaning holati / A. N. Zokirova, E. R. 111 Abdyukova, N. E. Zokirova // Kardiologiyada ratsional Farmakoterapiya. 2013;9(1):35-39.
  12. Surunkali yurak etishmovchiligida ayrim sitokinlar tarkibidagi o'zgarishlar / Kuzmin A. G. [va boshq.] // Qozon Tibbiyot Jurnali. 2012;3:494-498.
  13. Kakorin S.V. yurak-qon tomir kasalliklari bilan 2-toifa diabet mellitusli bemorlarda glisemik nazorat va gipoglikemik terapiya ( ko'p markazli randomizatsiyalangan klinik sinovlarni ko'rib chiqish) / S. V. Kakorin, R. A. Iskandaryan, A. M. Mkrtumyan // Qandli diabet. 2016;19(3):221-228.
  14. Metabolik sindrom: murakkab va hal qilinmagan muammolar / Chumakova G. A. [va boshqalar] //Rossiya yurak jurnali. 2014;3(107):63-71.

    file

    download